Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT07107555

Necrotizing Soft Tissue Infections

SnapNSTI: An International Time-bound Prospective Observational Cohort Study Addressing the Epidemiology and Management of Necrotizing Soft Tissue Infections

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
480 (estimated)
Sponsor
European Society for Trauma and Emergency Surgery · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

SnapNSTI is an international, multicenter, time-bound prospective observational cohort study designed to characterize current epidemiology, management patterns, and outcomes of patients with necrotizing soft-tissue infections (NSTI). The primary objective is to estimate 90-day all-cause mortality and to evaluate the variability in management across centers. The study will also explore the association between clinical characteristics, treatments, and patient-reported outcomes.

Detailed description

Necrotizing soft-tissue infections (NSTIs) are life-threatening surgical emergencies with high mortality despite timely surgical debridement and antibiotic treatment. Wide variability in treatment strategies-ranging from diagnostic imaging to operative timing and adjunctive therapies-contributes to outcome heterogeneity, yet no standardized, high-resolution prospective data exist to guide best practices. SnapNSTI is a time-bound, multicenter international observational cohort study coordinated by the Center for Emergency Surgery Outcomes Research (CESOR) at the University of Pennsylvania, and led by a consortium of international surgical societies. The study will enroll adult patients with confirmed NSTI over a 6-month window at each participating site within a 12-month period starting in 2026. The primary outcome is 90-day all-cause mortality. Secondary outcomes include organ support-free days, in-hospital complications, length of stay, and 60-day patient-reported outcomes (PROMs, including the EuroQol 5-Dimension 5-Level (EQ-5D-5L) instrument). Standardized definitions and real-time REDCap-based data collection will ensure data quality. Analyses will include multivariable regression, propensity score methods, and target trial emulation. Results will inform future interventional research and evidence-based guidelines.

Conditions

Timeline

Start date
2026-01-01
Primary completion
2027-03-31
Completion
2027-03-31
First posted
2025-08-06
Last updated
2025-08-06

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT07107555. Inclusion in this directory is not an endorsement.

Necrotizing Soft Tissue Infections (NCT07107555) · Clinical Trials Directory